1h Free Analyst Time
The global heart transplantation therapeutics market is forecasted to grow by USD 133.05 million during 2025-2030, accelerating at a CAGR of 3.0% during the forecast period. The report on the global heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of end-stage heart failure, technological advancements in organ preservation, breakthroughs in xenotransplantation and artificial heart technology.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global heart transplantation therapeutics market is segmented as below:
By Drug Class
- Immunosuppressants
- Anti-infectives
- Analgesics
- Others
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Type
- Left ventricular assist device (LVAD)
- Heart transplantation
- Implantable cardiac defibrillator (ICD)
- Extracorporeal membrane oxygenation (ECMO)
By Indication
- Ischemic heart disease (IHD)
- Dilated cardiomyopathy (DCM)
- Valvular heart disease (VHD)
- Hypertrophic cardiomyopathy (HCM)
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global heart transplantation therapeutics market covers the following areas:
- Global heart transplantation therapeutics market sizing
- Global heart transplantation therapeutics market forecast
- Global heart transplantation therapeutics market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Heart Transplantation Therapeutics Market 2020 - 2024
- Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2020 - 2024 ($ thousand)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Indication Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
6.1 Impact of AI on Global Heart Transplantation Therapeutics Market
6.2 Impact of Geopolitical Conflict on Global Heart Transplantation Therapeutics Market
6.2 Impact of Geopolitical Conflict on Global Heart Transplantation Therapeutics Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Drug Class
8.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ thousand)
- Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%)
- Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%)
- Chart on Anti-infectives - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Anti-infectives - Market size and forecast 2025-2030 ($ thousand)
- Chart on Anti-infectives - Year-over-year growth 2025-2030 (%)
- Data Table on Anti-infectives - Year-over-year growth 2025-2030 (%)
- Chart on Analgesics - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Analgesics - Market size and forecast 2025-2030 ($ thousand)
- Chart on Analgesics - Year-over-year growth 2025-2030 (%)
- Data Table on Analgesics - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ thousand)
- Data Table on Market opportunity by Drug Class ($ thousand)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ thousand)
- Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ thousand)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ thousand)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ thousand)
- Data Table on Market opportunity by Distribution Channel ($ thousand)
10 Market Segmentation by Type
10.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Left ventricular assist device (LVAD) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2025-2030 (%)
- Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2025-2030 (%)
- Chart on Heart transplantation - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Heart transplantation - Market size and forecast 2025-2030 ($ thousand)
- Chart on Heart transplantation - Year-over-year growth 2025-2030 (%)
- Data Table on Heart transplantation - Year-over-year growth 2025-2030 (%)
- Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2025-2030 (%)
- Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2025-2030 (%)
- Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2025-2030 (%)
- Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ thousand)
- Data Table on Market opportunity by Type ($ thousand)
11 Market Segmentation by Indication
11.1 Market segments
- Chart on Indication - Market share 2025-2030 (%)
- Data Table on Indication - Market share 2025-2030 (%)
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
- Chart on Ischemic heart disease (IHD) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Ischemic heart disease (IHD) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Ischemic heart disease (IHD) - Year-over-year growth 2025-2030 (%)
- Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2025-2030 (%)
- Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2025-2030 (%)
- Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2025-2030 (%)
- Chart on Valvular heart disease (VHD) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Valvular heart disease (VHD) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Valvular heart disease (VHD) - Year-over-year growth 2025-2030 (%)
- Data Table on Valvular heart disease (VHD) - Year-over-year growth 2025-2030 (%)
- Chart on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2025-2030 (%)
- Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2025-2030 (%)
- Market opportunity by Indication ($ thousand)
- Data Table on Market opportunity by Indication ($ thousand)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ thousand)
- Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ thousand)
- Data Table on US - Market size and forecast 2025-2030 ($ thousand)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ thousand)
- Data Table on France - Market size and forecast 2025-2030 ($ thousand)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ thousand)
- Data Table on China - Market size and forecast 2025-2030 ($ thousand)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ thousand)
- Data Table on India - Market size and forecast 2025-2030 ($ thousand)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ thousand)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Egypt - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Egypt - Market size and forecast 2025-2030 ($ thousand)
- Chart on Egypt - Year-over-year growth 2025-2030 (%)
- Data Table on Egypt - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Increasing prevalence of end-stage heart failure
- Technological advancements in organ preservation
- Breakthroughs in xenotransplantation and artificial heart technology
- High risk of post-transplant complications
- Shortage of donor organs
- High cost of treatment
- Impact of drivers and challenges in 2025 and 2030
- Shift towards personalized immunosuppression and biomarker-guided therapy
- Growing adoption of ex-vivo organ perfusion systems
- Emergence of novel biologics and cell-based therapies
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
- SWOT
- LEO Pharma AS - Overview
- LEO Pharma AS - Product / Service
- LEO Pharma AS - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- McKesson Corp. - Overview
- McKesson Corp. - Business segments
- McKesson Corp. - Key offerings
- McKesson Corp. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Strides Pharma Ltd. - Overview
- Strides Pharma Ltd. - Product / Service
- Strides Pharma Ltd. - Key offerings
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Type
Exhibit 8: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Drug Class Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - Indication Segment 2020 - 2024 ($ thousand)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 41: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Drug Class
Exhibit 43: Data Table on Comparison by Drug Class
Exhibit 44: Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ thousand)
Exhibit 45: Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ thousand)
Exhibit 46: Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Anti-infectives - Market size and forecast 2025-2030 ($ thousand)
Exhibit 49: Data Table on Anti-infectives - Market size and forecast 2025-2030 ($ thousand)
Exhibit 50: Chart on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Analgesics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 53: Data Table on Analgesics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 54: Chart on Analgesics - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Analgesics - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 57: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 58: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 60: Market opportunity by Drug Class ($ thousand)
Exhibit 61: Data Table on Market opportunity by Drug Class ($ thousand)
Exhibit 62: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 63: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 64: Chart on Comparison by Distribution Channel
Exhibit 65: Data Table on Comparison by Distribution Channel
Exhibit 66: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 67: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 68: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 70: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 71: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 72: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 75: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 76: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 78: Market opportunity by Distribution Channel ($ thousand)
Exhibit 79: Data Table on Market opportunity by Distribution Channel ($ thousand)
Exhibit 80: Chart on Type - Market share 2025-2030 (%)
Exhibit 81: Data Table on Type - Market share 2025-2030 (%)
Exhibit 82: Chart on Comparison by Type
Exhibit 83: Data Table on Comparison by Type
Exhibit 84: Chart on Left ventricular assist device (LVAD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 85: Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 86: Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2025-2030 (%)
Exhibit 88: Chart on Heart transplantation - Market size and forecast 2025-2030 ($ thousand)
Exhibit 89: Data Table on Heart transplantation - Market size and forecast 2025-2030 ($ thousand)
Exhibit 90: Chart on Heart transplantation - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on Heart transplantation - Year-over-year growth 2025-2030 (%)
Exhibit 92: Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 93: Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 94: Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 97: Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 98: Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2025-2030 (%)
Exhibit 100: Market opportunity by Type ($ thousand)
Exhibit 101: Data Table on Market opportunity by Type ($ thousand)
Exhibit 102: Chart on Indication - Market share 2025-2030 (%)
Exhibit 103: Data Table on Indication - Market share 2025-2030 (%)
Exhibit 104: Chart on Comparison by Indication
Exhibit 105: Data Table on Comparison by Indication
Exhibit 106: Chart on Ischemic heart disease (IHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 107: Data Table on Ischemic heart disease (IHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 108: Chart on Ischemic heart disease (IHD) - Year-over-year growth 2025-2030 (%)
Exhibit 109: Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2025-2030 (%)
Exhibit 110: Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 111: Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 112: Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2025-2030 (%)
Exhibit 114: Chart on Valvular heart disease (VHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 115: Data Table on Valvular heart disease (VHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 116: Chart on Valvular heart disease (VHD) - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Valvular heart disease (VHD) - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 119: Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 120: Chart on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2025-2030 (%)
Exhibit 122: Market opportunity by Indication ($ thousand)
Exhibit 123: Data Table on Market opportunity by Indication ($ thousand)
Exhibit 124: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 125: Chart on Market share by geography 2025-2030 (%)
Exhibit 126: Data Table on Market share by geography 2025-2030 (%)
Exhibit 127: Chart on Geographic comparison
Exhibit 128: Data Table on Geographic comparison
Exhibit 129: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 130: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 131: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Regional Comparison - North America
Exhibit 134: Data Table on Regional Comparison - North America
Exhibit 135: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 136: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 137: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 138: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 139: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 140: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 141: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 144: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 145: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 148: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 149: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Regional Comparison - Europe
Exhibit 152: Data Table on Regional Comparison - Europe
Exhibit 153: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 154: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 155: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 158: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 159: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 162: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 163: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 166: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 167: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 170: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 171: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 174: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 175: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 178: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 179: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Regional Comparison - Asia
Exhibit 182: Data Table on Regional Comparison - Asia
Exhibit 183: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 184: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 185: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 188: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 189: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 192: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 193: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 196: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 197: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Singapore - Market size and forecast 2025-2030 ($ thousand)
Exhibit 200: Data Table on Singapore - Market size and forecast 2025-2030 ($ thousand)
Exhibit 201: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 204: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 205: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 208: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 209: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 212: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 213: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 214: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 215: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 222: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 223: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 226: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 227: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 230: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 231: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Egypt - Market size and forecast 2025-2030 ($ thousand)
Exhibit 234: Data Table on Egypt - Market size and forecast 2025-2030 ($ thousand)
Exhibit 235: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 238: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 239: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 242: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 243: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 245: Market opportunity by geography ($ thousand)
Exhibit 246: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 247: Impact of drivers and challenges in 2025 and 2030
Exhibit 248: Overview on criticality of inputs and factors of differentiation
Exhibit 249: Overview on factors of disruption
Exhibit 250: Impact of key risks on business
Exhibit 251: Companies covered
Exhibit 252: Company ranking index
Exhibit 253: Matrix on companies position and classification
Exhibit 254: AbbVie Inc. - Overview
Exhibit 255: AbbVie Inc. - Business segments
Exhibit 256: AbbVie Inc. - Key news
Exhibit 257: AbbVie Inc. - Key offerings
Exhibit 258: AbbVie Inc. - Segment focus
Exhibit 259: SWOT
Exhibit 260: Astellas Pharma Inc. - Overview
Exhibit 261: Astellas Pharma Inc. - Product / Service
Exhibit 262: Astellas Pharma Inc. - Key news
Exhibit 263: Astellas Pharma Inc. - Key offerings
Exhibit 264: SWOT
Exhibit 265: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 266: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 267: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 268: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 269: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: F. Hoffmann La Roche Ltd. - Overview
Exhibit 272: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 273: F. Hoffmann La Roche Ltd. - Key news
Exhibit 274: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 275: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 276: SWOT
Exhibit 277: GlaxoSmithKline Plc - Overview
Exhibit 278: GlaxoSmithKline Plc - Business segments
Exhibit 279: GlaxoSmithKline Plc - Key news
Exhibit 280: GlaxoSmithKline Plc - Key offerings
Exhibit 281: GlaxoSmithKline Plc - Segment focus
Exhibit 282: SWOT
Exhibit 283: Intas Pharmaceuticals Ltd. - Overview
Exhibit 284: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 285: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Jubilant Pharmova Ltd. - Overview
Exhibit 288: Jubilant Pharmova Ltd. - Business segments
Exhibit 289: Jubilant Pharmova Ltd. - Key offerings
Exhibit 290: Jubilant Pharmova Ltd. - Segment focus
Exhibit 291: SWOT
Exhibit 292: LEO Pharma AS - Overview
Exhibit 293: LEO Pharma AS - Product / Service
Exhibit 294: LEO Pharma AS - Key offerings
Exhibit 295: SWOT
Exhibit 296: Lupin Ltd. - Overview
Exhibit 297: Lupin Ltd. - Business segments
Exhibit 298: Lupin Ltd. - Key news
Exhibit 299: Lupin Ltd. - Key offerings
Exhibit 300: Lupin Ltd. - Segment focus
Exhibit 301: SWOT
Exhibit 302: McKesson Corp. - Overview
Exhibit 303: McKesson Corp. - Business segments
Exhibit 304: McKesson Corp. - Key offerings
Exhibit 305: McKesson Corp. - Segment focus
Exhibit 306: SWOT
Exhibit 307: Novartis AG - Overview
Exhibit 308: Novartis AG - Business segments
Exhibit 309: Novartis AG - Key news
Exhibit 310: Novartis AG - Key offerings
Exhibit 311: Novartis AG - Segment focus
Exhibit 312: SWOT
Exhibit 313: Pfizer Inc. - Overview
Exhibit 314: Pfizer Inc. - Business segments
Exhibit 315: Pfizer Inc. - Key news
Exhibit 316: Pfizer Inc. - Key offerings
Exhibit 317: Pfizer Inc. - Segment focus
Exhibit 318: SWOT
Exhibit 319: Strides Pharma Ltd. - Overview
Exhibit 320: Strides Pharma Ltd. - Product / Service
Exhibit 321: Strides Pharma Ltd. - Key offerings
Exhibit 322: SWOT
Exhibit 323: Sun Pharmaceutical Industries - Overview
Exhibit 324: Sun Pharmaceutical Industries - Business segments
Exhibit 325: Sun Pharmaceutical Industries - Key news
Exhibit 326: Sun Pharmaceutical Industries - Key offerings
Exhibit 327: Sun Pharmaceutical Industries - Segment focus
Exhibit 328: SWOT
Exhibit 329: Teva Pharmaceutical Ltd. - Overview
Exhibit 330: Teva Pharmaceutical Ltd. - Business segments
Exhibit 331: Teva Pharmaceutical Ltd. - Key news
Exhibit 332: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 333: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 334: SWOT
Exhibit 335: Inclusions checklist
Exhibit 336: Exclusions checklist
Exhibit 337: Currency conversion rates for US$
Exhibit 338: Research methodology
Exhibit 339: Information sources
Exhibit 340: Data validation
Exhibit 341: Validation techniques employed for market sizing
Exhibit 342: Data synthesis
Exhibit 343: 360 degree market analysis
Exhibit 344: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Type
Exhibit 8: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Drug Class Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - Indication Segment 2020 - 2024 ($ thousand)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 41: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Drug Class
Exhibit 43: Data Table on Comparison by Drug Class
Exhibit 44: Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ thousand)
Exhibit 45: Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ thousand)
Exhibit 46: Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Anti-infectives - Market size and forecast 2025-2030 ($ thousand)
Exhibit 49: Data Table on Anti-infectives - Market size and forecast 2025-2030 ($ thousand)
Exhibit 50: Chart on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Anti-infectives - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Analgesics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 53: Data Table on Analgesics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 54: Chart on Analgesics - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Analgesics - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 57: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 58: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 60: Market opportunity by Drug Class ($ thousand)
Exhibit 61: Data Table on Market opportunity by Drug Class ($ thousand)
Exhibit 62: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 63: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 64: Chart on Comparison by Distribution Channel
Exhibit 65: Data Table on Comparison by Distribution Channel
Exhibit 66: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 67: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 68: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 69: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 70: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 71: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 72: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 75: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ thousand)
Exhibit 76: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 78: Market opportunity by Distribution Channel ($ thousand)
Exhibit 79: Data Table on Market opportunity by Distribution Channel ($ thousand)
Exhibit 80: Chart on Type - Market share 2025-2030 (%)
Exhibit 81: Data Table on Type - Market share 2025-2030 (%)
Exhibit 82: Chart on Comparison by Type
Exhibit 83: Data Table on Comparison by Type
Exhibit 84: Chart on Left ventricular assist device (LVAD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 85: Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 86: Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2025-2030 (%)
Exhibit 88: Chart on Heart transplantation - Market size and forecast 2025-2030 ($ thousand)
Exhibit 89: Data Table on Heart transplantation - Market size and forecast 2025-2030 ($ thousand)
Exhibit 90: Chart on Heart transplantation - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on Heart transplantation - Year-over-year growth 2025-2030 (%)
Exhibit 92: Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 93: Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 94: Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 97: Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 98: Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2025-2030 (%)
Exhibit 100: Market opportunity by Type ($ thousand)
Exhibit 101: Data Table on Market opportunity by Type ($ thousand)
Exhibit 102: Chart on Indication - Market share 2025-2030 (%)
Exhibit 103: Data Table on Indication - Market share 2025-2030 (%)
Exhibit 104: Chart on Comparison by Indication
Exhibit 105: Data Table on Comparison by Indication
Exhibit 106: Chart on Ischemic heart disease (IHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 107: Data Table on Ischemic heart disease (IHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 108: Chart on Ischemic heart disease (IHD) - Year-over-year growth 2025-2030 (%)
Exhibit 109: Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2025-2030 (%)
Exhibit 110: Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 111: Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 112: Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2025-2030 (%)
Exhibit 114: Chart on Valvular heart disease (VHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 115: Data Table on Valvular heart disease (VHD) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 116: Chart on Valvular heart disease (VHD) - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Valvular heart disease (VHD) - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 119: Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 120: Chart on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2025-2030 (%)
Exhibit 122: Market opportunity by Indication ($ thousand)
Exhibit 123: Data Table on Market opportunity by Indication ($ thousand)
Exhibit 124: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 125: Chart on Market share by geography 2025-2030 (%)
Exhibit 126: Data Table on Market share by geography 2025-2030 (%)
Exhibit 127: Chart on Geographic comparison
Exhibit 128: Data Table on Geographic comparison
Exhibit 129: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 130: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 131: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Regional Comparison - North America
Exhibit 134: Data Table on Regional Comparison - North America
Exhibit 135: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 136: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 137: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 138: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 139: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 140: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 141: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 144: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 145: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 148: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 149: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Regional Comparison - Europe
Exhibit 152: Data Table on Regional Comparison - Europe
Exhibit 153: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 154: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 155: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 158: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 159: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 162: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 163: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 166: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 167: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 170: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 171: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 174: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 175: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 178: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 179: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Regional Comparison - Asia
Exhibit 182: Data Table on Regional Comparison - Asia
Exhibit 183: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 184: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 185: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 188: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 189: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 192: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 193: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 196: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 197: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Singapore - Market size and forecast 2025-2030 ($ thousand)
Exhibit 200: Data Table on Singapore - Market size and forecast 2025-2030 ($ thousand)
Exhibit 201: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 204: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 205: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 208: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 209: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 212: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 213: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 214: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 215: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 218: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 219: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 222: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 223: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 226: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 227: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 230: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 231: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Egypt - Market size and forecast 2025-2030 ($ thousand)
Exhibit 234: Data Table on Egypt - Market size and forecast 2025-2030 ($ thousand)
Exhibit 235: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 238: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 239: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 242: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 243: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 245: Market opportunity by geography ($ thousand)
Exhibit 246: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 247: Impact of drivers and challenges in 2025 and 2030
Exhibit 248: Overview on criticality of inputs and factors of differentiation
Exhibit 249: Overview on factors of disruption
Exhibit 250: Impact of key risks on business
Exhibit 251: Companies covered
Exhibit 252: Company ranking index
Exhibit 253: Matrix on companies position and classification
Exhibit 254: AbbVie Inc. - Overview
Exhibit 255: AbbVie Inc. - Business segments
Exhibit 256: AbbVie Inc. - Key news
Exhibit 257: AbbVie Inc. - Key offerings
Exhibit 258: AbbVie Inc. - Segment focus
Exhibit 259: SWOT
Exhibit 260: Astellas Pharma Inc. - Overview
Exhibit 261: Astellas Pharma Inc. - Product / Service
Exhibit 262: Astellas Pharma Inc. - Key news
Exhibit 263: Astellas Pharma Inc. - Key offerings
Exhibit 264: SWOT
Exhibit 265: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 266: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 267: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 268: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 269: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: F. Hoffmann La Roche Ltd. - Overview
Exhibit 272: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 273: F. Hoffmann La Roche Ltd. - Key news
Exhibit 274: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 275: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 276: SWOT
Exhibit 277: GlaxoSmithKline Plc - Overview
Exhibit 278: GlaxoSmithKline Plc - Business segments
Exhibit 279: GlaxoSmithKline Plc - Key news
Exhibit 280: GlaxoSmithKline Plc - Key offerings
Exhibit 281: GlaxoSmithKline Plc - Segment focus
Exhibit 282: SWOT
Exhibit 283: Intas Pharmaceuticals Ltd. - Overview
Exhibit 284: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 285: Intas Pharmaceuticals Ltd. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Jubilant Pharmova Ltd. - Overview
Exhibit 288: Jubilant Pharmova Ltd. - Business segments
Exhibit 289: Jubilant Pharmova Ltd. - Key offerings
Exhibit 290: Jubilant Pharmova Ltd. - Segment focus
Exhibit 291: SWOT
Exhibit 292: LEO Pharma AS - Overview
Exhibit 293: LEO Pharma AS - Product / Service
Exhibit 294: LEO Pharma AS - Key offerings
Exhibit 295: SWOT
Exhibit 296: Lupin Ltd. - Overview
Exhibit 297: Lupin Ltd. - Business segments
Exhibit 298: Lupin Ltd. - Key news
Exhibit 299: Lupin Ltd. - Key offerings
Exhibit 300: Lupin Ltd. - Segment focus
Exhibit 301: SWOT
Exhibit 302: McKesson Corp. - Overview
Exhibit 303: McKesson Corp. - Business segments
Exhibit 304: McKesson Corp. - Key offerings
Exhibit 305: McKesson Corp. - Segment focus
Exhibit 306: SWOT
Exhibit 307: Novartis AG - Overview
Exhibit 308: Novartis AG - Business segments
Exhibit 309: Novartis AG - Key news
Exhibit 310: Novartis AG - Key offerings
Exhibit 311: Novartis AG - Segment focus
Exhibit 312: SWOT
Exhibit 313: Pfizer Inc. - Overview
Exhibit 314: Pfizer Inc. - Business segments
Exhibit 315: Pfizer Inc. - Key news
Exhibit 316: Pfizer Inc. - Key offerings
Exhibit 317: Pfizer Inc. - Segment focus
Exhibit 318: SWOT
Exhibit 319: Strides Pharma Ltd. - Overview
Exhibit 320: Strides Pharma Ltd. - Product / Service
Exhibit 321: Strides Pharma Ltd. - Key offerings
Exhibit 322: SWOT
Exhibit 323: Sun Pharmaceutical Industries - Overview
Exhibit 324: Sun Pharmaceutical Industries - Business segments
Exhibit 325: Sun Pharmaceutical Industries - Key news
Exhibit 326: Sun Pharmaceutical Industries - Key offerings
Exhibit 327: Sun Pharmaceutical Industries - Segment focus
Exhibit 328: SWOT
Exhibit 329: Teva Pharmaceutical Ltd. - Overview
Exhibit 330: Teva Pharmaceutical Ltd. - Business segments
Exhibit 331: Teva Pharmaceutical Ltd. - Key news
Exhibit 332: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 333: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 334: SWOT
Exhibit 335: Inclusions checklist
Exhibit 336: Exclusions checklist
Exhibit 337: Currency conversion rates for US$
Exhibit 338: Research methodology
Exhibit 339: Information sources
Exhibit 340: Data validation
Exhibit 341: Validation techniques employed for market sizing
Exhibit 342: Data synthesis
Exhibit 343: 360 degree market analysis
Exhibit 344: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global heart transplantation therapeutics market: AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Panacea Biotec Ltd., Pfizer Inc., RPG Life Sciences Ltd., Strides Pharma Ltd., Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is shift towards personalized immunosuppression and biomarker-guided therapy."
According to the report, one of the major drivers for this market is the increasing prevalence of end-stage heart failure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Astellas Pharma Inc.
- Biocon Ltd.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
- Jubilant Pharmova Ltd.
- LEO Pharma AS
- Lupin Ltd.
- McKesson Corp.
- Novartis AG
- Panacea Biotec Ltd.
- Pfizer Inc.
- RPG Life Sciences Ltd.
- Strides Pharma Ltd.
- Sun Pharmaceutical Industries
- Teva Pharmaceutical Ltd.
